Unknown

Dataset Information

0

Progress of stem/progenitor cell-based therapy for retinal degeneration.


ABSTRACT: Retinal degeneration (RD), such as age-related macular degeneration (AMD) and retinitis pigmentosa, is one of the leading causes of blindness. Presently, no satisfactory therapeutic options are available for these diseases principally because the retina and retinal pigmented epithelium (RPE) do not regenerate, although wet AMD can be prevented from further progression by anti-vascular endothelial growth factor therapy. Nevertheless, stem/progenitor cell approaches exhibit enormous potential for RD treatment using strategies mainly aimed at the rescue and replacement of photoreceptors and RPE. The sources of stem/progenitor cells are classified into two broad categories in this review, which are (1) ocular-derived progenitor cells, such as retinal progenitor cells, and (2) non-ocular-derived stem cells, including embryonic stem cells, induced pluripotent stem cells, and mesenchymal stromal cells. Here, we discuss in detail the progress in the study of four predominant stem/progenitor cell types used in animal models of RD. A short overview of clinical trials involving the stem/progenitor cells is also presented. Currently, stem/progenitor cell therapies for RD still have some drawbacks such as inhibited proliferation and/or differentiation in vitro (with the exception of the RPE) and limited long-term survival and function of grafts in vivo. Despite these challenges, stem/progenitor cells represent the most promising strategy for RD treatment in the near future.

SUBMITTER: Tang Z 

PROVIDER: S-EPMC5424366 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Progress of stem/progenitor cell-based therapy for retinal degeneration.

Tang Zhimin Z   Zhang Yi Y   Wang Yuyao Y   Zhang Dandan D   Shen Bingqiao B   Luo Min M   Gu Ping P  

Journal of translational medicine 20170510 1


Retinal degeneration (RD), such as age-related macular degeneration (AMD) and retinitis pigmentosa, is one of the leading causes of blindness. Presently, no satisfactory therapeutic options are available for these diseases principally because the retina and retinal pigmented epithelium (RPE) do not regenerate, although wet AMD can be prevented from further progression by anti-vascular endothelial growth factor therapy. Nevertheless, stem/progenitor cell approaches exhibit enormous potential for  ...[more]

Similar Datasets

| S-EPMC7511341 | biostudies-literature
| S-EPMC3999769 | biostudies-literature
| S-EPMC8327474 | biostudies-literature
| S-EPMC7199575 | biostudies-literature
| S-EPMC8667779 | biostudies-literature
| S-EPMC4640237 | biostudies-literature
| S-EPMC1682012 | biostudies-literature
| S-EPMC6037203 | biostudies-literature
| S-EPMC7696075 | biostudies-literature
| S-EPMC4300926 | biostudies-literature